Graham Capital Management, L.P. Kura Oncology, Inc. Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $136,508 - $239,347	10,172 New	10,172 $216,000
Q3 2023 Nov 22, 2023	SELL	$8.44 - $11.86 $80,070 - $112,515	-9,487 Reduced 30.99%	21,131 $192,000
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $294,545 - $428,345	30,618 New	30,618 $323,000
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $153,966 - $263,512	-14,376 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $169,349 - $244,104	14,376 New	14,376 $231,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.